Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2023-02-14
4:00 pm
Purchase		13GTonix Pharmaceuticals Holding Corp.
TNXP		TANG CAPITAL PARTNERS LP4,500,419
7.4%		219,503increase
(+5.13%)		View
2022-12-27
5:05 pm
Purchase		13GTonix Pharmaceuticals Holding Corp.
TNXP		TANG CAPITAL PARTNERS LP4,280,916
7.4%		4,280,916increase
(New Position)		View
2022-07-08
4:52 pm
Sale		13GTonix Pharmaceuticals Holding Corp.
TNXP		BlackRock Inc.
BLK		341,736
1.1%		-30,289,822decrease
(-98.88%)		View
2022-02-04
4:12 pm
Purchase		13GTonix Pharmaceuticals Holding Corp.
TNXP		BlackRock Inc.
BLK		30,631,558
6.2%		30,631,558increase
(New Position)		View
2021-02-16
5:09 pm
Sale		13GTonix Pharmaceuticals Holding Corp.
TNXP		ARMISTICE CAPITAL LLC0
0%		-598,399decrease
(Position Closed)		View
2021-02-16
10:09 am
Sale		13GTonix Pharmaceuticals Holding Corp.
TNXP		CVI Investments Inc.111,250
0.1%		-1,131,265decrease
(-91.05%)		View
2021-02-11
5:15 pm
Sale		13GTonix Pharmaceuticals Holding Corp.
TNXP		Altium Capital Management LP0
0%		-1,546,082decrease
(Position Closed)		View
2021-02-10
8:20 pm
Sale		13GTonix Pharmaceuticals Holding Corp.
TNXP		RENAISSANCE TECHNOLOGIES LLC271,164
0.14%		-49,061decrease
(-15.32%)		View
2021-01-04
6:42 pm
Sale		13GTonix Pharmaceuticals Holding Corp.
TNXP		SABBY MANAGEMENT LLC100,000
11%		-1,135,771decrease
(-91.91%)		View
2020-02-14
3:39 pm
Unchanged		13GTonix Pharmaceuticals Holding Corp.
TNXP		Altium Capital Management LP1,546,082
9.9%		0
(Unchanged)		View
2020-02-14
3:09 pm
Purchase		13GTonix Pharmaceuticals Holding Corp.
TNXP		ARMISTICE CAPITAL LLC598,399
9.99%		233,923increase
(+64.18%)		View
2020-02-14
10:22 am
Sale		13GTonix Pharmaceuticals Holding Corp.
TNXP		Iroquois Capital Management LLC100,000
2.4%		-900,000decrease
(-90.00%)		View
2020-02-14
09:03 am
Purchase		13GTonix Pharmaceuticals Holding Corp.
TNXP		CVI Investments Inc.1,242,515
9.9%		1,131,265increase
(+1016.87%)		View
2020-02-12
2:33 pm
Purchase		13GTonix Pharmaceuticals Holding Corp.
TNXP		RENAISSANCE TECHNOLOGIES LLC320,225
7.96%		320,225increase
(New Position)		View
2020-02-10
3:15 pm
Sale		13GTonix Pharmaceuticals Holding Corp.
TNXP		CVI Investments Inc.111,250
2.7%		-152,329decrease
(-57.79%)		View
2020-02-07
1:59 pm
Purchase		13GTonix Pharmaceuticals Holding Corp.
TNXP		SABBY MANAGEMENT LLC1,235,771
11%		1,157,166increase
(+1472.13%)		View
2020-01-21
1:03 pm
Sale		13GTonix Pharmaceuticals Holding Corp.
TNXP		SABBY MANAGEMENT LLC78,605
11%		-218,122decrease
(-73.51%)		View
2019-11-25
3:34 pm
Purchase		13GTonix Pharmaceuticals Holding Corp.
TNXP		Altium Capital Management LP1,546,082
9.9%		1,546,082increase
(New Position)		View
2019-11-22
5:42 pm
Purchase		13GTonix Pharmaceuticals Holding Corp.
TNXP		ARMISTICE CAPITAL LLC364,476
9.99%		364,476increase
(New Position)		View
2019-02-14
1:50 pm
Purchase		13GTonix Pharmaceuticals Holding Corp.
TNXP		Anson Funds Management LP298,571
4.9%		148,571increase
(+99.05%)		View
Goto 0, 1, Next